دورية أكاديمية
أعرض في EDS

Microneedle-based intradermal delivery of stabilized dengue virus.

التفاصيل البيبلوغرافية
العنوان: Microneedle-based intradermal delivery of stabilized dengue virus.
المؤلفون: Turvey ME; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore., Uppu DSSM; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore., Mohamed Sharif AR; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore., Bidet K; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore., Alonso S; Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, Immunology Programme Life Sciences Institute, National University of Singapore Singapore., Ooi EE; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore.; Emerging Infectious Diseases Duke-NUS Graduate Medical School Singapore., Hammond PT; Infectious Diseases IRG Singapore-MIT Alliance for Research and Technology Singapore.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge MA.; Department of Chemical Engineering Massachusetts Institute of Technology Cambridge MA.
المصدر: Bioengineering & translational medicine [Bioeng Transl Med] 2019 Feb 25; Vol. 4 (2), pp. e10127. Date of Electronic Publication: 2019 Feb 25 (Print Publication: 2019).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101689146 Publication Model: eCollection Cited Medium: Print ISSN: 2380-6761 (Print) Linking ISSN: 23806761 NLM ISO Abbreviation: Bioeng Transl Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Hoboken, NJ : John Wiley & Sons Inc., [2016]-
مستخلص: Current live-attenuated dengue vaccines require strict cold chain storage. Methods to preserve dengue virus (DENV) viability, which enable vaccines to be transported and administered at ambient temperatures, will be decisive towards the implementation of affordable global vaccination schemes with broad immunization coverage in resource-limited areas. We have developed a microneedle (MN)-based vaccine platform for the stabilization and intradermal delivery of live DENV from minimally invasive skin patches. Dengue virus-stabilized microneedle arrays (VSMN) were fabricated using saccharide-based formulation of virus and could be stored dry at ambient temperature up to 3 weeks with maintained virus viability. Following intradermal vaccination, VSMN-delivered DENV was shown to elicit strong neutralizing antibody responses and protection from viral challenge, comparable to that of the conventional liquid vaccine administered subcutaneously. This work supports the potential for MN-based dengue vaccine technology and the progression towards cold chain-independence. Dengue virus can be stabilized using saccharide-based formulations and coated on microneedle array vaccine patches for storage in dry state with preserved viability at ambient temperature (VSMN; virus-stabilized microneedle arrays).
Competing Interests: The authors have no conflicts of interest to declare.
References: Langmuir. 2015 Aug 11;31(31):8654-60. (PMID: 26145437)
Nat Mater. 2006 Aug;5(8):632-5. (PMID: 16845422)
J Control Release. 2012 Feb 28;158(1):78-84. (PMID: 22063004)
Biotechnol Prog. 1998 Jul-Aug;14(4):615-20. (PMID: 9694684)
Expert Rev Vaccines. 2008 Nov;7(9):1329-39. (PMID: 18980537)
J Control Release. 2016 Oct 10;239:19-26. (PMID: 27524283)
Vaccine. 2015 Sep 8;33(37):4712-8. (PMID: 25770786)
J Travel Med. 2016 Sep 13;23(6):. (PMID: 27625400)
J Infect Dis. 2018 Jun 5;218(1):124-132. (PMID: 29701813)
Cell. 2002 Mar 8;108(5):717-25. (PMID: 11893341)
Vaccine. 2010 Nov 3;28(47):7483-91. (PMID: 20851091)
Hum Vaccin. 2005 May-Jun;1(3):106-11. (PMID: 17012854)
Nat Med. 2002 Apr;8(4):415-9. (PMID: 11927950)
PLoS One. 2010 Oct 18;5(10):e13460. (PMID: 20976136)
Sci Rep. 2012;2:357. (PMID: 22500210)
Drug Deliv. 2016 Sep;23(7):2391-2398. (PMID: 25625495)
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6639-E6648. (PMID: 27702895)
J Control Release. 2010 Mar 3;142(2):187-95. (PMID: 19840825)
PLoS One. 2015 Mar 18;10(3):e0120797. (PMID: 25785935)
Vaccine. 2014 Mar 14;32(13):1431-5. (PMID: 24559895)
J Control Release. 2012 Apr 10;159(1):34-42. (PMID: 22245683)
Antiviral Res. 2015 Nov;123:5-14. (PMID: 26304704)
Gene Ther. 2010 Jun;17(6):811-4. (PMID: 20200562)
Lancet Infect Dis. 2017 Nov;17(11):e378-e382. (PMID: 28711586)
Expert Rev Vaccines. 2013 Aug;12(8):933-53. (PMID: 23984962)
PLoS Negl Trop Dis. 2017 Sep 21;11(9):e0005866. (PMID: 28934197)
Nature. 2013 Apr 25;496(7446):504-7. (PMID: 23563266)
Nat Microbiol. 2016 Sep 19;1:16164. (PMID: 27642668)
Sci Rep. 2018 Jul 25;8(1):11193. (PMID: 30046140)
J Travel Med. 2018 Aug 1;25(1):. (PMID: 30113689)
J Control Release. 2010 Dec 20;148(3):327-33. (PMID: 20850487)
J Control Release. 2010 Nov 1;147(3):326-32. (PMID: 20692307)
Vaccine. 2013 Jul 25;31(34):3396-402. (PMID: 23174199)
Bioeng Transl Med. 2019 Feb 25;4(2):e10127. (PMID: 31249877)
Vaccine. 2015 Dec 10;33(50):7100-11. (PMID: 26475445)
Clin Vaccine Immunol. 2013 Sep;20(9):1433-9. (PMID: 23863506)
Nat Med. 2010 Aug;16(8):915-20. (PMID: 20639891)
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7968-73. (PMID: 19416832)
Sci Transl Med. 2010 Feb 17;2(19):19ra12. (PMID: 20371486)
Small. 2010 Aug 16;6(16):1776-84. (PMID: 20665754)
Nat Immunol. 2016 Sep;17(9):1102-8. (PMID: 27339099)
Dev Biol Stand. 1996;87:219-25. (PMID: 8854020)
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7758-E7767. (PMID: 30065113)
Biomaterials. 2015 Jul;57:50-8. (PMID: 25913250)
Vaccine. 2015 Jan 1;33(1):62-72. (PMID: 25446819)
Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68. (PMID: 22575858)
Biomaterials. 2012 May;33(14):3756-69. (PMID: 22361098)
Biomed Microdevices. 2009 Feb;11(1):35-47. (PMID: 18663579)
Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):. (PMID: 28716893)
Nat Mater. 2013 Apr;12(4):367-76. (PMID: 23353628)
Bull World Health Organ. 2014 Feb 1;92(2):86-92. (PMID: 24623901)
Nat Rev Immunol. 2009 Oct;9(10):679-91. (PMID: 19763149)
Adv Healthc Mater. 2013 Oct;2(10):1401-10. (PMID: 23564440)
Curr Opin Immunol. 2017 Aug;47:64-69. (PMID: 28738289)
Colloids Surf B Biointerfaces. 2015 Feb 1;126:520-30. (PMID: 25612819)
Vaccine. 2013 Jul 25;31(34):3403-9. (PMID: 23044406)
Bioinspir Biomim. 2008 Dec;3(4):046001. (PMID: 18779629)
Nature. 1977 Feb 24;265(5596):739-41. (PMID: 404559)
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):18936-41. (PMID: 19864632)
Clin Vaccine Immunol. 2007 Apr;14(4):375-81. (PMID: 17329444)
J Control Release. 2012 Sep 28;162(3):529-37. (PMID: 22960496)
N Engl J Med. 2018 Jul 26;379(4):327-340. (PMID: 29897841)
J Control Release. 2013 Dec 10;172(2):579-88. (PMID: 23643528)
Expert Rev Vaccines. 2005 Aug;4(4):553-74. (PMID: 16117712)
Vaccine. 2015 Sep 8;33(37):4683-90. (PMID: 25749246)
ACS Nano. 2012 Sep 25;6(9):8041-51. (PMID: 22920601)
J Control Release. 2013 Mar 10;166(2):159-71. (PMID: 23246470)
J Control Release. 2016 Oct 28;240:135-141. (PMID: 26603347)
Nat Rev Immunol. 2015 Dec;15(12):745-59. (PMID: 26603900)
Adv Funct Mater. 2013 Jan 14;23(2):161-172. (PMID: 23503923)
J Leukoc Biol. 2008 Oct;84(4):1028-38. (PMID: 18653464)
J Control Release. 2016 Jul 10;233:101-13. (PMID: 27178811)
J Control Release. 2012 Apr 30;159(2):215-21. (PMID: 22306334)
Nat Med. 2000 Jul;6(7):816-20. (PMID: 10888933)
Adv Healthc Mater. 2014 Jan;3(1):47-58. (PMID: 23847143)
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5005-10. (PMID: 25848020)
فهرسة مساهمة: Keywords: dengue; immunization cold chain; microneedles; vaccine delivery
تواريخ الأحداث: Date Created: 20190629 Latest Revision: 20231012
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC6584444
DOI: 10.1002/btm2.10127
PMID: 31249877
قاعدة البيانات: MEDLINE
الوصف
تدمد:2380-6761
DOI:10.1002/btm2.10127